BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12480574)

  • 21. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
    Guo T; Zhang XL; Chang RM; Zhang YZ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):946-8. PubMed ID: 13129729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions.
    Kim MJ; Kim JH; Choi JY; Park SH; Chung JJ; Kim KW; Mitchell DG
    AJR Am J Roentgenol; 2006 Sep; 187(3):W255-66. PubMed ID: 16928903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superparamagnectic iron oxide-enhanced magnetic resonance for tumor surveillance in cirrhotic liver before liver transplantation with explanted liver correlation.
    Tsang LL; Chen CL; Huang TL; Chen TY; Ou HY; Eng HL; Concejero A; Yu CY; Chen HL; Cheng YF
    Transplant Proc; 2011 Jun; 43(5):1674-7. PubMed ID: 21693256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule.
    Takeshita K; Nagashima I; Frui S; Takada K; Yamauchi T; Harasawa A; Oba H; Kohtake H; Tanaka H; Suzuki S
    J Comput Assist Tomogr; 2002; 26(3):451-5. PubMed ID: 12016379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging.
    van den Bos IC; Hussain SM; Terkivatan T; Zondervan PE; de Man RA
    J Magn Reson Imaging; 2006 Nov; 24(5):1071-80. PubMed ID: 17024654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases.
    Ward J; Guthrie JA; Sheridan MB; Boyes S; Smith JT; Wilson D; Wyatt JI; Treanor D; Robinson PJ
    J Clin Oncol; 2008 Sep; 26(26):4304-10. PubMed ID: 18779617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic malignant tumour versus cavernous haemangioma: differentiation on multiple breath-hold turbo spin-echo MRI sequences with different T2-weighting and T2-relaxation time measurements on a single slice multi-echo sequence.
    Chan YL; Lee SF; Yu SC; Lai P; Ching AS
    Clin Radiol; 2002 Apr; 57(4):250-7. PubMed ID: 12014868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
    Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
    Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of fat-suppressed T1-weighted MRI using orally administered superparamagnetic iron oxide for revealing ampullary carcinomas.
    Kim YK; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(4):519-25. PubMed ID: 17882025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
    Suto Y; Kato T; Matsuo T; Kamba M; Shimatani Y; Ohuchi Y; Nakamura K; Ohta Y
    Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of superparamagnetic iron oxide particles in the detection of hepatocellular carcinoma by MR imaging].
    Hirohashi S; Uchida H; Ohimichi R; Kitano S; Tanaka M; Ohishi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):469-71. PubMed ID: 8388092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced multi-shot echo-planar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast-enhanced spin-echo T1-weighted imaging.
    Tomura N; Narita K; Takahashi S; Otani T; Sakuma I; Yasuda K; Nishii T; Watarai J
    Acta Radiol; 2007 Nov; 48(9):1032-7. PubMed ID: 17957522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents.
    Mergo PJ; Engelken JD; Helmberger T; Ros PR
    J Magn Reson Imaging; 1998; 8(5):1073-8. PubMed ID: 9786144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration.
    Grandin C; Van Beers BE; Robert A; Gigot JF; Geubel A; Pringot J
    J Comput Assist Tomogr; 1995; 19(3):412-8. PubMed ID: 7790551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Iron oxide-enhanced MR imaging of hepatocellular carcinoma of woodchuck].
    Ohtomo K; Shiga J; Sasaki Y; Itai Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Apr; 51(4):433-5. PubMed ID: 1648709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
    Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis.
    Ward J; Chen F; Guthrie JA; Wilson D; Lodge JP; Wyatt JI; Robinson PJ
    Radiology; 2000 Jan; 214(1):159-66. PubMed ID: 10644117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.